Intended for healthcare professionals

Rapid response to:

Editorials

Treatment of postmenopausal osteoporosis

BMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7496.859 (Published 14 April 2005) Cite this as: BMJ 2005;330:859

Rapid Response:

Monitor the treatment

I would caution everyone treating osteoporosis to monitor their treatment since dangerous drug induced adverse effects could occur, like hypercalcemia, renal stones, gastritis, exacerbation of post menopausal symptoms, deep vein thrombosis & rarely malignancies.

Competing interests: None declared

Competing interests: No competing interests

02 May 2005
milind m deshpande
consultant orthosurgeon
hubli,india,580031